51
|
Masuda M, Chen WY, Miyanaga A, Nakamura Y, Kawasaki K, Sakuma T, Ono M, Chen CL, Honda K, Yamada T. Correction: Alternative mammalian target of rapamycin (mTOR) signal activation in sorafenib-resistant hepatocellular carcinoma cells revealed by array-based pathway profiling. Mol Cell Proteomics 2020; 19:223. [PMID: 31894100 DOI: 10.1074/mcp.aac119.001903] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
52
|
Li H, Vossen A, Aihara H, Asner D, Aulchenko V, Aushev T, Babu V, Badhrees I, Bakich A, Bennett J, Bhardwaj V, Bilka T, Biswal J, Bobrov A, Bračko M, Campajola M, Cao L, Červenkov D, Chekelian V, Chen A, Cheon B, Cho H, Cho K, Choi Y, Choudhury S, Cinabro D, Cunliffe S, Di Capua F, Di Carlo S, Dong T, Eidelman S, Ferber T, Fulsom B, Gaur V, Garmash A, Giri A, Goldenzweig P, Hartbrich O, Hayasaka K, Hayashii H, Huang K, Inami K, Ishikawa A, Itoh R, Iwasaki M, Jacobs W, Jang EJ, Jia S, Jin Y, Kang K, Karyan G, Kim D, Kim S, Kodyš P, Korpar S, Kotchetkov D, Križan P, Kroeger R, Krokovny P, Kwon YJ, Lee S, Li Y, Li Gioi L, Libby J, Lieret K, Liventsev D, Luo T, MacQueen C, Masuda M, Matsuda T, Merola M, Miyabayashi K, Miyata H, Mizuk R, Mussa R, Nakano T, Nakao M, Naruki M, Nath K, Natkaniec Z, Nishida S, Ono H, Ostrowicz W, Pakhlov P, Pakhlova G, Pal B, Pardi S, Patra S, Paul S, Pedlar T, Pestotnik R, Piilonen L, Popov V, Prencipe E, Prim M, Russo G, Sahoo D, Sakai Y, Santelj L, Sanuki T, Savinov V, Schneider O, Schnell G, Schueler J, Schwanda C, Seidl R, Seino Y, Senyo K, Shiu JG, Simon F, Solovieva E, Starič M, Stottler Z, Takizawa M, Tanida K, Tenchini F, Uchida M, Uglov T, Uno S, Van Tonder R, Varner G, Wang B, Wang C, Wang MZ, Wang P, Watanabe M, Won E, Yang S, Ye H, Zhang Z, Zhilich V, Zhukova V, Zhulanov V. Azimuthal asymmetries of back-to-back
π±−(π0, η, π±)
pairs in
e+e−
annihilation. Int J Clin Exp Med 2019. [DOI: 10.1103/physrevd.100.092008] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
53
|
Jin Y, Aihara H, Epifanov D, Adachi I, Al Said S, Asner D, Aulchenko V, Aushev T, Ayad R, Babu V, Badhrees I, Bahinipati S, Bansal V, Behera P, Berger M, Bhardwaj V, Bilka T, Biswal J, Bobrov A, Bonvicini G, Bozek A, Bračko M, Campajola M, Cao L, Červenkov D, Chekelian V, Chen A, Cheon B, Chilikin K, Cho H, Cho K, Choi Y, Choudhury S, Cinabro D, Cunliffe S, Di Carlo S, Doležal Z, Dong T, Dossett D, Eidelman S, Fast J, Ferber T, Fulsom B, Garg R, Gaur V, Gabyshev N, Garmash A, Giri A, Goldenzweig P, Golob B, Greenwald D, Grzymkowska O, Haba J, Hayasaka K, Hayashii H, Hedges M, Hou WS, Huang K, Iijima T, Inami K, Inguglia G, Ishikawa A, Iwasaki M, Iwasaki Y, Jacobs W, Jeon H, Jia S, Joffe D, Joo K, Kahn J, Kaliyar A, Karyan G, Kawasaki T, Kichimi H, Kiesling C, Kim D, Kim H, Kim K, Kim S, Kinoshita K, Kodyš P, Korpar S, Kotchetkov D, Križan P, Kroeger R, Krokovny P, Kulasiri R, Kumar R, Kuzmin A, Kwon YJ, Lalwani K, Lange J, Lee J, Lee S, Li C, Li L, Li Y, Li Gioi L, Libby J, Lieret K, Liptak Z, Liventsev D, Lu PC, Luo T, MacNaughton J, Masuda M, Matsuda T, Matvienko D, Merola M, Miyabayashi K, Miyata H, Mizuk R, Mori T, Mussa R, Nakano E, Nakao M, Nath K, Natkaniec Z, Nayak M, Niiyama M, Nisar N, Nishida S, Ogawa S, Ono H, Onuki Y, Pakhlov P, Pakhlova G, Pal B, Pardi S, Park H, Park SH, Patra S, Paul S, Pedlar T, Pestotnik R, Piilonen L, Popov V, Prencipe E, Purohit M, Rostomyan A, Russo G, Sahoo D, Sakai Y, Salehi M, Sandilya S, Santelj L, Sanuki T, Savinov V, Schneider O, Schnell G, Schueler J, Schwanda C, Seino Y, Senyo K, Seon O, Sevior M, Shebalin V, Shen C, Shiu JG, Shwartz B, Simon F, Singh J, Sokolov A, Solovieva E, Stanič S, Starič M, Stottler Z, Strube J, Sumiyoshi T, Takizawa M, Tamponi U, Tanida K, Tenchini F, Trabelsi K, Uchida M, Uglov T, Unno Y, Uno S, Urquijo P, Usov Y, Van Tonder R, Varner G, Vinokurova A, Vorobyev V, Vossen A, Wang B, Wang C, Wang MZ, Wang P, Watanuki S, Won E, Yang S, Ye H, Yin J, Yuan C, Yusa Y, Zhang Z, Zhilich V, Zhukova V. Observation of
τ−→π−ντe+e−
and search for
τ−→π−ντμ+μ−. Int J Clin Exp Med 2019. [DOI: 10.1103/physrevd.100.071101] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
54
|
Kameda Y, Morohoshi T, Koga H, Ando K, Tsuura Y, Masuda M. EP1.01-100 Evaluation of the Clinicopathological Features of Patients in Whom Residual Carcinoma in Bronchial Stump After Surgery for Lung Cancer. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.2072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
55
|
Masuda H, Arai H, Mishina Y, Nakamura S, Shiino K, Okudela K, Iwasawa T, Tajiri M, Masuda M. EP1.09-09 Surgical Cases of Pulmonary Pleomorphic Carcinoma at Our Institution. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.2205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
56
|
Nemoto D, Ito H, Tsuboi T, Eriguchi D, Samejima J, Nagashima T, Nakayama H, Masuda M. P2.18-17 Outcome of Surgical Treatment for Clinical N1 Non-Small Cell Lung Cancer. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1971] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
57
|
Hata Y, Iida O, Asai M, Masuda M, Okamoto S, Ishihara T, Nanto K, Kanda T, Tsujimura T, Okuno S, Matsuda Y, Mano T. P4711The prognostic impact of infrapopliteal arterial calcification on wound healing in patients with critical limb ischemia. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.1092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Critical limb ischemia (CLI) is the most progressed manifestation of peripheral artery disease. Although patients with CLI commonly complicate with severely calcified lesions in infrapopliteal lesions, the prognostic impact of infrapopliteal arterial calcification on wound healing in patients with CLI has not been systematically studied.
Purpose
The aim of current study was to elucidate the prognostic impact of infrapopliteal arterial calcification on wound healing in CLI undergoing endovascular therapy (EVT).
Methods
This study enrolled 639 CLI patients with tissue loss (age 74±10 years, male 62%, diabetes 69%, hemodialysis 57%, Rutherford class 5 77%, class 6 23%) primarily treated with EVT for the infrapopliteal lesions between April 2010 and December 2015. Arterial calcification was assessed by high intensity fluoroscopy and classified into 3 groups as follows; 1) none, 2) unilateral and 3) bilateral calcification. The primary outcome measure was complete wound healing. The predictors of the outcome were evaluated by Cox proportional hazards regression analysis.
Results
During a mean follow-up period of 22±19 months, 1-year wound healing rate were 59.0%. In Kaplan-Meier analysis, 1-year wound healing rate was worse in patients with bilateral calcification than in those with unilateral or none calcification (Figure, 46.2% versus 55.1% versus 67.8%, P<0.001). After multivariate analysis, the predictors of wound healing were non-ambulatory status (hazard ratio (HR) 0.67 [95% confidential interval (CI) 0.53–0.85], P=0.001) and bilateral calcification (HR 0.75 [95% CI 0.47–0.98], versus none or unilateral calcification, P=0.036).
Figure 1
Conclusion
Infrapopliteal Arterial calcification as well as non-ambulatory status was associated with wound healing in patients with CLI.
Collapse
|
58
|
Kamiya M, Miyagi Y, Kamioka Y, Yotsumoto H, Inoue H, Murakawa M, Nakamura Y, Yoshihara M, Yamada T, Yamamoto N, Oshima T, Shiozawa M, Yukawa N, Rino Y, Masuda M, Morinaga S. Expression of long noncoding RNA and clinical outcomes of pancreatic cancer patients who received adjuvant chemotherapy by S-1 or GEM after curative resection. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz247.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
59
|
Matsubara Y, Yamanaka T, Yamashita T, Okamoto S, Toda S, Kohagura K, Sugawara Y, Yamanaka A, Suganuma N, Nakayama H, Yoshida T, Iwasaki H, Rino Y, Masuda M. Re-sentinel node biopsy for local recurrence after breast-conserving surgery. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz241.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
60
|
Masuda M, Kanda T, Asai M, Mano T, Yamada T, Yasumura Y, Uematsu M, Hikoso S, Nakatani D, Tamaki S, Higuchi Y, Nakagawa Y, Fuji H, Abe H, Sakata Y. P6356Comparisons of clinical outcomes in patients with heart failure with preserved ejection fraction with and without atrial fibrillation: results from a multicenter PURSUIT-HFpEF registry. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0952] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Background
The presence of atrial fibrillation (AF) has been demonstrated to be associated with poor clinical outcomes in heart failure patients with reduced ejection fraction.
Objective
This study aimed to elucidate the impact of the presence of atrial fibrillation (AF) on the clinical characteristics, therapeutics, and outcomes in patients with heart failure and preserved ejection fraction (HFpEF).
Methods
PURSUIT-HFpEF is a multicenter prospective observational study including patients hospitalized for acute heart failure with left ventricular ejection fraction of >50%. Patients with acute coronary syndrome or severe valvular disease were excluded.
Results
Of 486 HFpEF patients (age, 80.8±9.0 years old; male, 47%) from 24 cardiovascular centers, 199 (41%) had AF on admission. Patients with AF had lower systolic blood pressures (142±27 vs. 155±35mmHg, p<0.0001) and higher heart rates (91±29 vs. 82±26bpm, p<0.0001) than those without. There was no difference in the usage of inotropes or mechanical ventilation between the 2 groups. A higher quality of life score (EQ5D, 0.72±0.27 vs. 0.63±0.30, p=0.002) was observed at discharge in patients with than without AF. In addition, AF patients tended to demonstrate lower in-hospital mortality rates (0.5% vs. 2.4%, p=0.09) and shorter hospital stays (20.3±12.1 vs. 22.6±18.4 days, p=0.09) than those without. During a mean follow up of 360±111 days, mortality (14.1% vs. 15.3) and heart failure re-hospitalization rates (13.1% vs. 13.9%) were comparable between the 2 groups.
Conclusion
In contrast to heart failure patients with reduced ejection fraction, AF on admission was not associated with poor long-term clinical outcomes among HFpEF patients. Several in-hospital outcomes were better in patients with AF than in those without.
Acknowledgement/Funding
None
Collapse
|
61
|
Tsujimura T, Ishihara T, Iida O, Asai M, Masuda M, Okamoto S, Nanto K, Kanda T, Okuno S, Matsuda Y, Mano T. P3386Angioscopic comparison between polymer-free biolimus A9-coated stent and durable polymer drug-eluting stent 10 months after the implantation. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0262] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Polymer-free biolimus A9-coated stent (DCS) has currently emerged as expected better arterial healing compared to durable polymer drug-eluting stent (DP-DES). However, superiority of DCS on arterial healing over DP-DES has not been well elucidated using intracoronary images.
Methods
This study examined 288 stents in 224 patients with de novo coronary artery lesions. We angioscopically compared 55 DCS from 35 patients with 233 DP-DES from 189 patients 10±2 months after the implantation. We assessed thrombus adhesion, which is a marker of incomplete re-endothelialization. Dominant neointimal coverage (NIC) grade, heterogeneity of NIC and maximum yellow color of plaque underneath the stent were also evaluated. Neointimal coverage was graded as follows: grade 0, stent struts exposed; grade 1, struts bulged into the lumen, although covered; grade 2, struts embedded by the neointima, but translucent; grade 3, struts fully embedded and invisible. NIC was judged as heterogeneous when differences in the NIC grade became apparent. Yellow plaque was graded as follows: grade 0, white; grade 1, light yellow; grade 2, yellow; grade 3, intensive yellow.
Results
Thrombus adhesion was similar between DCS and DP-DES (29% versus 23%, P=0.32). Dominant NIC was greater in DCS than in BP-DES (P<0.001), while NIC was more heterogeneous in DCS than in BP-DES (P=0.001, Figure). Maximum yellow color of stented segment was similar between DCS and DP-DES (P=0.09).
Conclusion
DCS provided similar thrombus adhesion to DP-DES, which suggested similar re-endothelialization 10 months after implantation. However, DCS showed thick and heterogeneous NIC compared to DP-DES. The specific feature of polymer-free and Biolimus A9 would cause the difference, and further investigation is necessary to evaluate the longer-term safety and efficacy.
Acknowledgement/Funding
None
Collapse
|
62
|
Kanda T, Masuda M, Shizuta S, Kobori A, Inoue K, Kaitani K, Kurotobi T, Morishima I, Nakazawa Y, Tsujimura T, Iida O, Asai M, Mano T. P1035Factors associated with quality-of-life improvement after catheter ablation of atrial fibrillation: insights from the Kansai Plus Atrial Fibrillation (KPAF) registry. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz747.0626] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Improving the quality of life (QoL) is one of the main purposes of catheter ablation (CA) of persistent atrial fibrillation (AF). Factors associated with QoL improvement after CA of AF patients have not been clarified. The Kansai Plus Atrial Fibrillation (KPAF) Registry is a multi-center registry enrolling more than 5,000 consecutive patients undergoing the first radiofrequency catheter ablation of AF.
Purpose
The aim of this study was to investigate the QoL change after AF ablation and its associated factors.
Methods
A total of 2030 patients in whom the QoL score was assessed before and one year after the ablation were enrolled from the KPAF registry (age 64±10 years, 75% male, paroxysmal 66%, CHADS2 score 1.1±1.1). The QoL was evaluated using the AF specific QoL evaluation method (AFQLQ), which scores the patient QoL within a range of 0–98 points.
Results
Overall, catheter ablation showed a significant increase in the AFQLQ score (68±19 vs. 86±13 points, P<0.01). AF recurrence was observed in 372 cases (18%) during a 1-year follow-up period. A multivariate analysis showed that AF recurrence, symptomatic AF, long AF duration, high preprocedural heart rate (>110 bpm) and small left atrial diameter were independent predictors of a QoL improvement defined as a >10% score increase.
Multivariate analysis
Conclusions
CA of AF significantly improved the QoL. AF recurrence was one of the strong factors associated with QoL improvement. Symptomatic AF, long AF duration, high preprocedural heart rate and small left atrial diameter were independent predictors of QoL improvement.
Collapse
|
63
|
Arai H, Tajiri M, Mishina Y, Nakamura S, Masuda H, Shiino K, Okudela K, Iwasawa T, Masuda M. P2.05-05 Availability of Four Dimensional Computed Tomography (4DCT) for Lung Cancer. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1604] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
64
|
Kanda T, Masuda M, Asai M, Iida O, Okamoto S, Ishihara T, Nanto K, Tsujimura T, Matsuda Y, Okuno S, Mano T. P1916A novel echo-guided approach of cryoballoon ablation without using contrast medium. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.0663] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Pulmonary vein isolation (PVI) using cryoballoon requires contrast medium injection for the confirmation of appropriate venous occlusion. However, some patients have contra-indications against contrast use such as allergy for contrast medium, bronchial asthma or renal dysfunction. We hypothesized that intra-cardiac echocardiographic observation of microbubble leakage after saline injection from the cryoballoon lumen can be used as a maker of incomplete venous occlusion.
Purpose
The aim of this study was to assess the effect of echo-guided approach using saline injection on the acute clinical outcomes as well as the amount of contrast medium.
Methods
Twenty consecutive patients with paroxysmal atrial fibrillation (AF) were studied. They had any reason to avoid using contrast medium. Plain CT scan was performed in all cases to understand the anatomical features. Intra-cardiac echocardiography was used in all cases to guide transseptal puncture and to confirm pulmonary-vein occlusion. Procedural results and clinical outcomes were compared with patients who were performed by the conventional method (n=279).
Results
In all study patients, we could perform PVI without using contrast medium. A total of 2 patients required touch-up ablation using radiofrequency ablation catheter. The procedure time (85±23 vs 86±27 min, P=0.84), the dose of radiation exposure (108±78 vs. 140±133 mmGy/m2, P=0.29), and ratio of requiring touch-up ablation (5% vs 4%, P=0.81) were similar between the study group and the reference group. There was no significant difference in the AF-free survival rate (73% vs. 76%, P=0.79) during a follow-up period of 14±6 months.
Images of ICE
Conclusion
Echo-guided approach using saline infusion was effective and less invasive in terms of reduction of contrast use.
Collapse
|
65
|
Okuno S, Ishihara T, Iida O, Asai M, Masuda M, Okamoto S, Nanto K, Kanda T, Tsujimura T, Matsuda Y, Hata Y, Uematsu H, Sato Y, Mano T. P6241Two-year clinical outcomes of biodegradable polymer versus durable polymer drug-eluting stent implantation in hemodialysis patients after percutaneous coronary intervention. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0842] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Biodegradable polymer drug-eluting stent (BP-DES) has been developed to improve clinical outcomes after percutaneous coronary intervention (PCI) for patients presenting coronary artery disease (CAD). Although BP-DES showed non-inferior safety and efficacy to durable polymer DES (DP-DES) in several randomized clinical trials, hemodialysis (HD) patients, who have been well known as high risk population for adverse events, were excluded in the most of trials. Therefore, there are limited data comparing the clinical outcomes between BP-DES and DP-DES in HD patients with CAD after PCI.
Purpose
The purpose of this study was to investigate clinical outcomes in HD patients after BP-DES implantation compared with those after DP-DES implantation.
Methods
We retrospectively analyzed 234 HD patients (male 74%, mean age 71±10 years) undergoing PCI for 404 lesions with 472 DESs (71 patients for 138 lesions with 170 BP-DESs [91 Ultimaster and 79 Synergy] and 163 HD patients for 266 lesions with 302 DP-DESs [219 Xience, 53 Promus and 30 Resolute]) from 2011 to 2017. Two-year clinical outcomes were compared between BP-DES group and DP-DES group. The primary outcome measure was the incidence of target lesion revascularization (TLR), while the secondary outcome measures were the occurrence of cardiac death (CD), stent thrombosis (ST), myocardial infraction (MI), target vessel revascularization (TVR), non-TVR and major adverse cardiac event (MACE) defined as a composite of CD, MI, and TVR. Outcome measures were estimated by the Kaplan-Meier method and the differences between BP-DES group and DP-DES group were assessed by the log-rank test. We also conducted Cox's proportional hazard model to identify predictors for TLR occurrence.
Results
Baseline patient and lesion characteristics were similar between the two groups. The two-year incidence of TLR was not significantly different between BP-DES group and DP-DES group (14.1% vs. 22.2%, p=0.391). The two-year incidences of CD (17.3% vs. 17.5%, p=0.381), ST (0% vs. 3.9%, p=0.133), MI (4.2% vs. 5.8%, p=0.965), TVR (21.3% vs. 27.5%, p=0.586), non-TVR (26.1% vs. 31.3%, p=0.439) and MACE (41.1% vs. 42.6%, p=0.526) were also not different between the two groups. After multivariate analysis, diabetes mellitus (hazard ratio 1.97; 95% confidence interval 1.03–3.78, p=0.004) was independently associated with TLR occurrence in HD patients.
Two-year clinical outcomes of HD patient
Conclusions
At two-year follow-up after PCI, BP-DES had comparable safety and efficacy profiles to DP-DES in HD patients presenting CAD.
Acknowledgement/Funding
None
Collapse
|
66
|
Koga H, Morohoshi T, Ando K, Kameda Y, Masuda M. P2.10-12 Clinicopathological Analysis of the Lung Cancer Patients Who Have History of Asbestos Exposure. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1696] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
67
|
Iwaya T, Endo F, Sasaki Y, Sasaki N, Yaegashi M, Akiyama Y, Sasaki A, Masuda M, Yamada T, Tokino T, Nishizuka SS. Abstract 2284: Patient-specific circulating tumor DNA monitoring using esophageal squamous cell cancer gene panel and digital PCR. Cancer Res 2019. [DOI: 10.1158/1538-7445.am2019-2284] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Esophageal squamous cell carcinoma (ESCC) is belligerent cancer with poor prognosis. At present, no specific ESCC biomarkers have been established for therapeutic monitoring. This study aimed to monitor ESCC therapeutic response using circulating tumor DNA (ctDNA) using digital PCR (dPCR) with individual ESCC tumor-specific mutations as identified from the originally-designed ESCC-specific next generation sequencing (NGS) panel.
Methods: Thirty-five ESCC patients were enrolled in our study (stage I/II/III/IV: 8/3/19/5, respectively). First-line therapies included surgery, chemotherapy with cisplatin/5-FU, and docetaxel/cisplatin/5-FU for 8, 3, and 24 patients, respectively. Mutation screening of primary ESCCs was performed with amplicon sequencing using ESCC panel, targeting 31 genes. The level of ctDNAs was evaluated by dPCR using 58 originally-designed sets by Hypercool Primer & ProbeTM based on mutations of the individual patient. A total of 458 blood samples were examined for ctDNA with a median follow-up time of 392 days. NGS screening of TP53 gene in plasma DNA was also performed.
Results: Among mutations whose variant allele frequency (VAF) was higher than 5%, the ESCC panel identified 5.1 mutations per sample. The most frequent mutated gene was TP53 (33 of 36, 92%). Among the 58 mutations identified from primary tumors analyzed by dPCR in pretreatment blood, 44 (76%) were detectable as ctDNA. The VAFs of plasma DNA in advanced stages were significantly higher than those of early stages (p < 0.0001). The rate of positive ctDNA was 12.5% (1/8) in stage I, whereas that of stage II or higher was 92.3% (24/26). In stage II or higher, the average tumor volume was 65,572 mm3 (range 3,816-521,818 mm3). There was a low correlation between tumor volume and ctDNA-VAF (r=0.51, 95%CI: 0.13-0.76). Sensitivity/specificity and positive/negative predictive value of ctDNA in plasma were 73.5%/93.5% and 96.2%/70.0%, respectively. These data suggest that ctDNA has higher credibility than conventional serum tumor makers, such as CEA, SCC, and CYFRA. In chemotherapy patients, those with a detectable level of ctDNA (n = 12) showed poorer survival than those with an undetectable level of ctDNA (n = 13) (hazard ratio: 0.12, 95% CI, 0.03-0.49, p = 0.001, log-rank). The VAFs of primary tumor mutations by both NGS and dPCR were strongly correlated (n = 59, r = 0.97), whereas the correlation between NGS and dPCR for VAFs of ctDNA for TP53 mutations in pretreatment plasma was relatively modest (r = 0.71), likely because of low VAFs (<1%). In a relapsed patient, ctDNA elevation was observed six months before the lymph node metastasis was diagnosed by CT scan 1.5 years after resection with curative intent for stage II ESCC.
Conclusion: With the ESCC panel and dPCR, patient-specific ctDNA monitoring readily indicates the disease stage and may facilitate an early relapse detection of ESCC.
Citation Format: Takeshi Iwaya, Fumitaka Endo, Yasushi Sasaki, Noriyuki Sasaki, Mizunori Yaegashi, Yuji Akiyama, Akira Sasaki, Mari Masuda, Tesshi Yamada, Takashi Tokino, Satoshi S. Nishizuka. Patient-specific circulating tumor DNA monitoring using esophageal squamous cell cancer gene panel and digital PCR [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 2284.
Collapse
|
68
|
Pal B, Adachi I, Adamczyk K, Aihara H, Asner D, Atmacan H, Aulchenko V, Aushev T, Ayad R, Babu V, Badhrees I, Bansal V, Behera P, Beleño C, Berger M, Bhardwaj V, Bhuyan B, Bilka T, Biswal J, Bobrov A, Bozek A, Bračko M, Browder T, Campajola M, Cao L, Červenkov D, Chekelian V, Chen A, Cheon B, Chilikin K, Cho K, Choi SK, Choi Y, Cinabro D, Cunliffe S, Di Carlo S, Doležal Z, Dong T, Dossett D, Eidelman S, Epifanov D, Fast J, Ferber T, Fulsom B, Garg R, Gaur V, Gabyshev N, Garmash A, Giri A, Goldenzweig P, Guan Y, Haba J, Hara T, Hayasaka K, Hayashii H, Hou WS, Hsu CL, Iijima T, Inami K, Ishikawa A, Itoh R, Iwasaki M, Iwasaki Y, Jacobs W, Jia S, Jin Y, Joffe D, Joo K, Kaliyar A, Karyan G, Kichimi H, Kiesling C, Kim C, Kim D, Kim K, Kim S, Kinoshita K, Kodyš P, Korpar S, Kotchetkov D, Križan P, Kroeger R, Krokovny P, Kulasiri R, Kwon YJ, Lee J, Lee S, Li L, Li Y, Li Gioi L, Libby J, Liventsev D, Lu PC, Luo T, MacNaughton J, MacQueen C, Masuda M, Matsuda T, Matvienko D, Merola M, Miyabayashi K, Miyata H, Mizuk R, Mohanty G, Nakao M, Nath K, Nayak M, Nisar N, Nishida S, Nishimura K, Ogawa S, Ono H, Onuki Y, Pakhlov P, Pakhlova G, Pardi S, Park SH, Patra S, Paul S, Pedlar T, Pestotnik R, Piilonen L, Popov V, Prencipe E, Rostomyan A, Russo G, Sakai Y, Salehi M, Sandilya S, Sanuki T, Savinov V, Schneider O, Schnell G, Schueler J, Schwanda C, Schwartz A, Seino Y, Senyo K, Sevior M, Shen C, Shiu JG, Simon F, Sokolov A, Solovieva E, Starič M, Stottler Z, Strube J, Sumiyoshi T, Sutcliffe W, Takizawa M, Tamponi U, Tanida K, Tenchini F, Uchida M, Uglov T, Uno S, Urquijo P, Van Tonder R, Varner G, Vinokurova A, Wang B, Wang C, Wang MZ, Wang P, Watanabe M, Watanuki S, Won E, Yang S, Ye H, Yelton J, Yusa Y, Zhang J, Zhang Z, Zhilich V, Zhukova V. Evidence for the decay
B0→pp¯π0. Int J Clin Exp Med 2019. [DOI: 10.1103/physrevd.99.091104] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
69
|
Masuda M. Hunting hidden pieces of signaling pathways in hepatocellular carcinoma. Hepatobiliary Surg Nutr 2019; 8:74-76. [PMID: 30881973 DOI: 10.21037/hbsn.2018.10.10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
70
|
Li YB, Shen CP, Yuan CZ, Adachi I, Aihara H, Al Said S, Asner DM, Aushev T, Ayad R, Badhrees I, Ban Y, Bansal V, Beleño C, Berger M, Bhardwaj V, Bhuyan B, Bilka T, Biswal J, Bondar A, Bozek A, Bračko M, Cao L, Červenkov D, Chen A, Cheon BG, Chilikin K, Cho K, Choi SK, Choi Y, Cinabro D, Cunliffe S, Di Carlo S, Doležal Z, Dong TV, Drásal Z, Eidelman S, Fast JE, Fulsom BG, Garg R, Gaur V, Gabyshev N, Garmash A, Giri A, Goldenzweig P, Greenwald D, Grube B, Hayasaka K, Hayashii H, Hsu CL, Iijima T, Inami K, Inguglia G, Ishikawa A, Itoh R, Iwasaki M, Iwasaki Y, Jacobs WW, Jia S, Jin Y, Joffe D, Joo KK, Karyan G, Kawasaki T, Kichimi H, Kim DY, Kim HJ, Kim JB, Kim KT, Kim SH, Kinoshita K, Kodyš P, Korpar S, Kotchetkov D, Križan P, Kroeger R, Krokovny P, Kumita T, Kuzmin A, Kwon YJ, Lee JY, Lee SC, Li LK, Li Gioi L, Libby J, Liventsev D, Lubej M, MacNaughton J, Masuda M, Matsuda T, Merola M, Miyabayashi K, Miyata H, Mizuk R, Mohanty GB, Mussa R, Nakano E, Nakao M, Nath KJ, Nayak M, Niiyama M, Nishida S, Ono H, Onuki Y, Pakhlov P, Pakhlova G, Pal B, Pardi S, Park SH, Paul S, Pedlar TK, Pestotnik R, Piilonen LE, Popov V, Prencipe E, Russo G, Sakai Y, Salehi M, Sandilya S, Santelj L, Sanuki T, Savinov V, Schneider O, Schnell G, Schueler J, Schwanda C, Schwartz AJ, Seino Y, Senyo K, Sevior ME, Shibata TA, Shiu JG, Shwartz B, Solovieva E, Starič M, Sumihama M, Sumiyoshi T, Sutcliffe W, Takizawa M, Tanida K, Tao Y, Tenchini F, Trabelsi K, Uchida M, Uglov T, Unno Y, Uno S, Urquijo P, Van Tonder R, Varner G, Wang B, Wang CH, Wang MZ, Wang P, Wang XL, Won E, Yang SB, Ye H, Yelton J, Yin JH, Yusa Y, Zhang ZP, Zhilich V, Zhukova V. First Measurements of Absolute Branching Fractions of the Ξ_{c}^{0} Baryon at Belle. PHYSICAL REVIEW LETTERS 2019; 122:082001. [PMID: 30932568 DOI: 10.1103/physrevlett.122.082001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/24/2018] [Revised: 01/27/2019] [Indexed: 06/09/2023]
Abstract
We present the first measurements of absolute branching fractions of Ξ_{c}^{0} decays into Ξ^{-}π^{+}, ΛK^{-}π^{+}, and pK^{-}K^{-}π^{+} final states. The measurements are made using a dataset comprising (772±11)×10^{6} BB[over ¯] pairs collected at the ϒ(4S) resonance with the Belle detector at the KEKB e^{+}e^{-} collider. We first measure the absolute branching fraction for B^{-}→Λ[over ¯]_{c}^{-}Ξ_{c}^{0} using a missing-mass technique; the result is B(B^{-}→Λ[over ¯]_{c}^{-}Ξ_{c}^{0})=(9.51±2.10±0.88)×10^{-4}. We subsequently measure the product branching fractions B(B^{-}→Λ[over ¯]_{c}^{-}Ξ_{c}^{0})B(Ξ_{c}^{0}→Ξ^{-}π^{+}), B(B^{-}→Λ[over ¯]_{c}^{-}Ξ_{c}^{0})B(Ξ_{c}^{0}→ΛK^{-}π^{+}), and B(B^{-}→Λ[over ¯]_{c}^{-}Ξ_{c}^{0})B(Ξ_{c}^{0}→pK^{-}K^{-}π^{+}) with improved precision. Dividing these product branching fractions by the result for B^{-}→Λ[over ¯]_{c}^{-}Ξ_{c}^{0} yields the following branching fractions: B(Ξ_{c}^{0}→Ξ^{-}π^{+})=(1.80±0.50±0.14)%, B(Ξ_{c}^{0}→ΛK^{-}π^{+})=(1.17±0.37±0.09)%, and B(Ξ_{c}^{0}→pK^{-}K^{-}π^{+})=(0.58±0.23±0.05)%. For the above branching fractions, the first uncertainties are statistical and the second are systematic. Our result for B(Ξ_{c}^{0}→Ξ^{-}π^{+}) can be combined with Ξ_{c}^{0} branching fractions measured relative to Ξ_{c}^{0}→Ξ^{-}π^{+} to yield other absolute Ξ_{c}^{0} branching fractions.
Collapse
|
71
|
Sumihama M, Adachi I, Ahn JK, Aihara H, Al Said S, Asner DM, Atmacan H, Aushev T, Ayad R, Babu V, Badhrees I, Bahinipati S, Bakich AM, Bansal V, Beleño C, Berger M, Bhardwaj V, Bhuyan B, Bilka T, Biswal J, Bonvicini G, Bozek A, Bračko M, Browder TE, Červenkov D, Chekelian V, Chen A, Cheon BG, Chilikin K, Cho K, Choi SK, Choi Y, Choudhury S, Cinabro D, Cunliffe S, Czank T, Dash N, Di Carlo S, Doležal Z, Dong TV, Drásal Z, Eidelman S, Epifanov D, Fast JE, Fulsom BG, Garg R, Gaur V, Gabyshev N, Garmash A, Gelb M, Giri A, Goldenzweig P, Guido E, Haba J, Hayasaka K, Hayashii H, Hirose S, Hou WS, Inami K, Inguglia G, Ishikawa A, Itoh R, Iwasaki M, Iwasaki Y, Jacobs WW, Jeon HB, Jia S, Jin Y, Joo KK, Julius T, Kaliyar AB, Kang KH, Karyan G, Kato Y, Kiesling C, Kim DY, Kim JB, Kim KT, Kim SH, Kinoshita K, Kodyš P, Korpar S, Kotchetkov D, Križan P, Kroeger R, Krokovny P, Kumar R, Kuzmin A, Kwon YJ, Lange JS, Lee IS, Lee SC, Li LK, Li YB, Li Gioi L, Libby J, Liventsev D, Lubej M, Luo T, Masuda M, Matsuda T, Matvienko D, Merola M, Miyabayashi K, Miyata H, Mizuk R, Mohanty GB, Moon HK, Mori T, Mussa R, Nakano E, Nakano T, Nakao M, Nanut T, Nath KJ, Natkaniec Z, Niiyama M, Nisar NK, Nishida S, Ono H, Pakhlov P, Pakhlova G, Pal B, Pardi S, Park H, Paul S, Pedlar TK, Pestotnik R, Piilonen LE, Popov V, Ritter M, Russo G, Sahoo D, Sandilya S, Santelj L, Sanuki T, Savinov V, Schneider O, Schnell G, Schwanda C, Seino Y, Senyo K, Sevior ME, Shebalin V, Shen CP, Shibata TA, Shiu JG, Shwartz B, Simon F, Sokolov A, Solovieva E, Starič M, Strube JF, Sumiyoshi T, Takizawa M, Tamponi U, Tanida K, Taniguchi N, Tenchini F, Uchida M, Uglov T, Uno S, Urquijo P, Vahsen SE, Van Hulse C, Varner G, Vorobyev V, Vossen A, Wang B, Wang CH, Wang MZ, Wang P, Wang XL, Watanabe M, Watanuki S, Widmann E, Won E, Ye H, Yelton J, Yuan CZ, Yusa Y, Zakharov S, Zhang ZP, Zhilich V, Zhukova V, Zhulanov V. Observation of Ξ(1620)^{0} and Evidence for Ξ(1690)^{0} in Ξ_{c}^{+}→Ξ^{-}π^{+}π^{+} Decays. PHYSICAL REVIEW LETTERS 2019; 122:072501. [PMID: 30848612 DOI: 10.1103/physrevlett.122.072501] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/15/2018] [Revised: 01/08/2019] [Indexed: 06/09/2023]
Abstract
We report the first observation of the double strange baryon Ξ(1620)^{0} in its decay to Ξ^{-}π^{+} via Ξ_{c}^{+}→Ξ^{-}π^{+}π^{+} decays based on a 980 fb^{-1} data sample collected with the Belle detector at the KEKB asymmetric-energy e^{+}e^{-} collider. The mass and width are measured to be 1610.4±6.0(stat)_{-4.2}^{+6.1} (syst) MeV/c^{2} and 59.9±4.8(stat)_{-7.1}^{+2.8}(syst) MeV, respectively. We obtain 4.0σ evidence of the Ξ(1690)^{0} with the same data sample. These results shed light on the structure of hyperon resonances with strangeness S=-2.
Collapse
|
72
|
Guan Y, Vossen A, Adachi I, Adamczyk K, Ahn JK, Aihara H, Al Said S, Asner DM, Atmacan H, Aulchenko V, Aushev T, Ayad R, Babu V, Badhrees I, Bakich AM, Bansal V, Behera P, Beleño C, Berger M, Bhardwaj V, Bhuyan B, Bilka T, Biswal J, Bobrov A, Bonvicini G, Bozek A, Bračko M, Browder TE, Cao L, Červenkov D, Chang P, Chekelian V, Chen A, Cheon BG, Chilikin K, Cho K, Choi SK, Choi Y, Cinabro D, Cunliffe S, Dash N, Di Carlo S, Dingfelder J, Doležal Z, Dong TV, Drásal Z, Eidelman S, Epifanov D, Fast JE, Ferber T, Fulsom BG, Garg R, Gaur V, Gabyshev N, Garmash A, Gelb M, Giri A, Goldenzweig P, Golob B, Guido E, Haba J, Hayasaka K, Hayashii H, Hirose S, Hou WS, Iijima T, Inami K, Inguglia G, Ishikawa A, Itoh R, Iwasaki M, Iwasaki Y, Jacobs WW, Jaegle I, Jeon HB, Jia S, Jin Y, Joffe D, Joo KK, Julius T, Kang KH, Kawasaki T, Kiesling C, Kim DY, Kim HJ, Kim JB, Kim KT, Kim SH, Kinoshita K, Kodyš P, Korpar S, Kotchetkov D, Križan P, Kroeger R, Krokovny P, Kuhr T, Kulasiri R, Kuzmin A, Kwon YJ, Lange JS, Lee IS, Lee SC, Li LK, Li YB, Li Gioi L, Libby J, Liventsev D, Lubej M, Luo T, Masuda M, Matsuda T, Matvienko D, Merola M, Miyata H, Mizuk R, Mohanty GB, Moon HK, Mori T, Mussa R, Nakao M, Nanut T, Nath KJ, Natkaniec Z, Nayak M, Niiyama M, Nisar NK, Nishida S, Ogawa S, Okuno S, Ono H, Pakhlov P, Pakhlova G, Pal B, Pardi S, Park H, Paul S, Pedlar TK, Pestotnik R, Piilonen LE, Popov V, Prencipe E, Rabusov A, Rostomyan A, Russo G, Sahoo D, Sakai Y, Salehi M, Sandilya S, Santelj L, Sanuki T, Savinov V, Schneider O, Schnell G, Schwanda C, Seidl R, Seino Y, Senyo K, Seon O, Sevior ME, Shebalin V, Shen CP, Shibata TA, Shiu JG, Simon F, Sokolov A, Solovieva E, Starič M, Strube JF, Sumihama M, Sumiyoshi T, Sutcliffe W, Suzuki K, Takizawa M, Tamponi U, Tanida K, Tenchini F, Uchida M, Uglov T, Unno Y, Uno S, Urquijo P, Usov Y, Vahsen SE, Van Hulse C, Van Tonder R, Varner G, Vinokurova A, Vorobyev V, Waheed E, Wang B, Wang CH, Wang MZ, Wang P, Wang XL, Watanuki S, Widmann E, Won E, Ye H, Yelton J, Yin JH, Yuan CZ, Yusa Y, Zhang ZP, Zhilich V, Zhukova V, Zhulanov V, Zupanc A. Observation of Transverse Λ/Λ[over ¯] Hyperon Polarization in e^{+}e^{-} Annihilation at Belle. PHYSICAL REVIEW LETTERS 2019; 122:042001. [PMID: 30768311 DOI: 10.1103/physrevlett.122.042001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/15/2018] [Revised: 12/21/2018] [Indexed: 06/09/2023]
Abstract
We report the first observation of the spontaneous polarization of Λ and Λ[over ¯] hyperons transverse to the production plane in e^{+}e^{-} annihilation, which is attributed to the effect arising from a polarizing fragmentation function. For inclusive Λ/Λ[over ¯] production, we also report results with subtracted feed-down contributions from Σ^{0} and charm. This measurement uses a dataset of 800.4 fb^{-1} collected by the Belle experiment at or near a center-of-mass energy of 10.58 GeV. We observe a significant polarization that rises with the fractional energy carried by the Λ/Λ[over ¯] hyperon.
Collapse
|
73
|
Seong IS, Vahsen SE, Adachi I, Aihara H, Al Said S, Asner DM, Aulchenko V, Aushev T, Ayad R, Babu V, Bakich AM, Bansal V, Behera P, Bhardwaj V, Bhuyan B, Bilka T, Biswal J, Bobrov A, Bonvicini G, Bozek A, Bračko M, Browder TE, Cao L, Červenkov D, Chang P, Chekelian V, Chen A, Cheon BG, Chilikin K, Cho K, Choi Y, Choudhury S, Cinabro D, Cunliffe S, Dash N, Di Carlo S, Dingfelder J, Dong TV, Eidelman S, Epifanov D, Fast JE, Frey A, Fulsom BG, Garg R, Gaur V, Gabyshev N, Garmash A, Gelb M, Giri A, Goldenzweig P, Golob B, Guido E, Haba J, Hayasaka K, Hayashii H, Hedges MT, Higuchi T, Hou WS, Hsu CL, Huang K, Iijima T, Inami K, Inguglia G, Ishikawa A, Itoh R, Iwasaki M, Iwasaki Y, Jacobs WW, Jeon HB, Jia S, Jin Y, Joffe D, Joo KK, Julius T, Kaliyar AB, Karyan G, Kawasaki T, Kichimi H, Kiesling C, Kim DY, Kim JB, Kim KT, Kim SH, Kinoshita K, Kodyš P, Korpar S, Kotchetkov D, Križan P, Kroeger R, Krokovny P, Kuhr T, Kumita T, Kuzmin A, Kwon YJ, Lange JS, Lee IS, Lee SC, Li LK, Li YB, Li Gioi L, Libby J, Liventsev D, Lubej M, Luo T, MacQueen C, Masuda M, Matsuda T, Merola M, Miyabayashi K, Miyata H, Mizuk R, Mohanty GB, Mori T, Mussa R, Nakano E, Nakao M, Nanut T, Nath KJ, Nayak M, Niiyama M, Nisar NK, Nishida S, Nishimura K, Ogawa S, Ono H, Ostrowicz W, Pakhlov P, Pakhlova G, Pal B, Park H, Pedlar TK, Pestotnik R, Piilonen LE, Prencipe E, Ritter M, Rostomyan A, Russo G, Sakai Y, Salehi M, Sandilya S, Santelj L, Sanuki T, Savinov V, Schneider O, Schnell G, Schueler J, Schwanda C, Seino Y, Senyo K, Seon O, Sevior ME, Shen CP, Shibata TA, Shiu JG, Simon F, Solovieva E, Stanič S, Starič M, Sumihama M, Sumiyoshi T, Sutcliffe W, Takizawa M, Tanida K, Tenchini F, Trabelsi K, Uchida M, Uglov T, Unno Y, Uno S, Usov Y, Van Hulse C, Van Tonder R, Varner G, Vinokurova A, Vossen A, Wang B, Wang CH, Wang P, Watanabe M, Watanuki S, Widmann E, Won E, Yamamoto H, Ye H, Yelton J, Yuan CZ, Yusa Y, Zakharov S, Zhang ZP, Zhilich V, Zhukova V, Zhulanov V, Zupanc A. Search for a Light CP-odd Higgs Boson and Low-Mass Dark Matter at the Belle Experiment. PHYSICAL REVIEW LETTERS 2019; 122:011801. [PMID: 31012694 DOI: 10.1103/physrevlett.122.011801] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/14/2018] [Indexed: 06/09/2023]
Abstract
We report on the first Belle search for a light CP-odd Higgs boson, A^{0}, that decays into low mass dark matter, χ, in final states with a single photon and missing energy. We search for events produced via the dipion transition ϒ(2S)→ϒ(1S)π^{+}π^{-}, followed by the on-shell process ϒ(1S)→γA^{0} with A^{0}→χχ, or by the off-shell process ϒ(1S)→γχχ. Utilizing a data sample of 157.3×10^{6} ϒ(2S) decays, we find no evidence for a signal. We set limits on the branching fractions of such processes in the mass ranges M_{A^{0}}<8.97 GeV/c^{2} and M_{χ}<4.44 GeV/c^{2}. We then use the limits on the off-shell process to set competitive limits on WIMP-nucleon scattering in the WIMP mass range below 5 GeV/c^{2}.
Collapse
|
74
|
Masuda M, Yamada T. Utility of Reverse-Phase Protein Array for Refining Precision Oncology. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2019; 1188:239-249. [PMID: 31820392 DOI: 10.1007/978-981-32-9755-5_13] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
Despite the early successes of targeted therapies and continuous improvements in next-generation sequencing technology over the last two decades, genomics-driven precision oncology has helped only a minority of cancer patients; thus treatment regimens are still not matched to the vast majority of cancer patients. It has become apparent that genomic profiling in itself is limited with respect to optimal selection of patients for targeted therapy. Proteomics-based approaches (in contrast to genomics-based and transcriptomics-based approaches) capture biological processes (e.g., diversity of protein expression patterns and post-translational modifications) directly contributing to cancer pathogenesis. This encourages incorporation of concordant proteomic analyses into the next stage of precision oncology. Reverse-phase protein array (RPPA) is well suited to pharmacodynamic analysis due to its ability to precisely map signaling status using limited amounts of clinical sample. In addition, the cost-effectiveness and rapid turnaround time of the RPPA platform offer a substantial advantage over existing molecular profiling technologies in a clinical setting. In this chapter, we begin by reviewing the current status of genomics-driven precision oncology, along with its limitations and challenges. Finally, we discuss the utility of RPPA technology as a means of improving precision oncology.
Collapse
|
75
|
Adachi I, Adye T, Ahmed H, Ahn JK, Aihara H, Akar S, Alam MS, Albert J, Anulli F, Arnaud N, Asner DM, Aston D, Atmacan H, Aushev T, Ayad R, Babu V, Badhrees I, Bakich AM, Banerjee S, Bansal V, Barlow RJ, Batignani G, Beaulieu A, Behera P, Bellis M, Ben-Haim E, Bernard D, Bernlochner FU, Bettarini S, Bettoni D, Bevan AJ, Bhardwaj V, Bhuyan B, Bianchi F, Biasini M, Biswal J, Blinov VE, Bomben M, Bondar A, Bonneaud GR, Bozek A, Bozzi C, Bračko M, Browder TE, Brown DN, Brown DN, Bünger C, Burchat PR, Buzykaev AR, Calabrese R, Calcaterra A, Calderini G, Di Carlo S, Carpinelli M, Cartaro C, Casarosa G, Cenci R, Chao DS, Chauveau J, Cheaib R, Chen A, Chen C, Cheng CH, Cheon BG, Chilikin K, Cho K, Choi Y, Choudhury S, Chrzaszcz M, Cibinetto G, Cinabro D, Cochran J, Coleman JP, Convery MR, Cowan G, Cowan R, Cremaldi L, Cunliffe S, Dash N, Davier M, Davis CL, De Mori F, De Nardo G, Denig AG, de Sangro R, Dey B, Di Lodovico F, Dittrich S, Doležal Z, Dorfan J, Drásal Z, Druzhinin VP, Dunwoodie W, Ebert M, Echenard B, Eidelman S, Eigen G, Eisner AM, Emery S, Epifanov D, Ernst JA, Faccini R, Fast JE, Feindt M, Ferber T, Ferrarotto F, Ferroni F, Field RC, Filippi A, Finocchiaro G, Fioravanti E, Flood KT, Forti F, Fritsch M, Fulsom BG, Gabathuler E, Gamba D, Garg R, Garmash A, Gary JW, Garzia I, Gaur V, Gaz A, Gelb M, Gershon TJ, Li Gioi L, Giorgi MA, Giri A, Godang R, Goldenzweig P, Golob B, Golubev VB, Gorodeisky R, Gradl W, Graham MT, Grauges E, Griessinger K, Gritsan AV, Grünberg O, Guan Y, Guido E, Guttman N, Haba J, Hafner A, Hara T, Harrison PF, Hast C, Hayasaka K, Hayashii H, Hearty C, Heck M, Hedges MT, Heß M, Hirose S, Hitlin DG, Honscheid K, Hou WS, Hsu CL, Huard Z, Van Hulse C, Hutchcroft DE, Inami K, Inguglia G, Innes WR, Ishikawa A, Itoh R, Iwasaki M, Iwasaki Y, Izen JM, Jacobs WW, Jawahery A, Jessop CP, Jia S, Jin Y, Joo KK, Julius T, Kaliyar AB, Kang KH, Karyan G, Kass R, Kichimi H, Kim DY, Kim JB, Kim KT, Kim SH, Kim J, Kim P, King GJ, Kinoshita K, Koch H, Kodyš P, Kolomensky YG, Korpar S, Kotchetkov D, Kowalewski R, Kravchenko EA, Križan P, Kroeger R, Krokovny P, Kuhr T, Kulasiri R, Kumita T, Kuzmin A, Kwon YJ, Lacker HM, Lafferty GD, Lanceri L, Lange JS, Lange DJ, Lankford AJ, Latham TE, Leddig T, Le Diberder F, Lee IS, Lee SC, Lees JP, Leith DWGS, Li LK, Li YB, Li Y, Libby J, Liventsev D, Lockman WS, Long O, LoSecco JM, Lou XC, Lubej M, Lueck T, Luitz S, Luo T, Luppi E, Lusiani A, Lutz AM, MacFarlane DB, MacNaughton J, Mallik U, Manoni E, Marchiori G, Margoni M, Martellotti S, Martinez-Vidal F, Masuda M, Matsuda T, Mattison TS, Matvienko D, McKenna JA, Meadows BT, Merola M, Miyabayashi K, Miyashita TS, Miyata H, Mizuk R, Mohanty GB, Moon HK, Mori T, Muller DR, Müller T, Mussa R, Nakano E, Nakao M, Nanut T, Nath KJ, Nayak M, Neal H, Neri N, Nisar NK, Nishida S, Nugent IM, Oberhof B, Ocariz J, Ogawa S, Ongmongkolkul P, Ono H, Onuchin AP, Onuki Y, Oyanguren A, Pakhlov P, Pakhlova G, Pal B, Palano A, Palombo F, Panduro Vazquez W, Paoloni E, Pardi S, Park H, Passaggio S, Patrignani C, Patteri P, Paul S, Pavelkin I, Payne DJ, Pedlar TK, Peimer DR, Peruzzi IM, Pestotnik R, Piccolo M, Piilonen LE, Pilloni A, Piredda G, Poireau V, Popov V, Porter FC, Posocco M, Prell S, Prepost R, Puccio EMT, Purohit MV, Pushpawela BG, Rama M, Randle-Conde A, Ratcliff BN, Raven G, Resmi PK, Ritchie JL, Ritter M, Rizzo G, Roberts DA, Robertson SH, Röhrken M, Roney JM, Roodman A, Rossi A, Rotondo M, Rozanska M, Russo G, Sacco R, Al Said S, Sakai Y, Salehi M, Sandilya S, Santelj L, Santoro V, Sanuki T, Savinov V, Schneider O, Schnell G, Schroeder T, Schubert KR, Schwanda C, Schwartz AJ, Schwitters RF, Sciacca C, Seddon RM, Seino Y, Sekula SJ, Senyo K, Seon O, Serednyakov SI, Sevior ME, Shebalin V, Shen CP, Shibata TA, Shimizu N, Shiu JG, Simi G, Simon F, Simonetto F, Skovpen YI, Smith JG, Smith AJS, So RY, Sobie RJ, Soffer A, Sokoloff MD, Solodov EP, Solovieva E, Spanier SM, Starič M, Stroili R, Sullivan MK, Sumisawa K, Sumiyoshi T, Summers DJ, Sun L, Takizawa M, Tamponi U, Tanida K, Taras P, Tasneem N, Tenchini F, Tisserand V, Todyshevx KY, Touramanis C, Uchida M, Uglov T, Unno Y, Uno S, Vahsen SE, Varner G, Vasseur G, Va'vra J, Červenkov D, Verderi M, Vitale L, Vorobyev V, Voß C, Wagner SR, Waheed E, Waldi R, Walsh JJ, Wang B, Wang CH, Wang MZ, Wang P, Watanabe Y, Wilson FF, Wilson JR, Wisniewski WJ, Won E, Wormser G, Wright DM, Wu SL, Ye H, Yuan CZ, Yusa Y, Zakharov S, Zallo A, Zani L, Zhang ZP, Zhilich V, Zhukova V, Zhulanov V, Zupanc A. First Evidence for cos2β>0 and Resolution of the Cabibbo-Kobayashi-Maskawa Quark-Mixing Unitarity Triangle Ambiguity. PHYSICAL REVIEW LETTERS 2018; 121:261801. [PMID: 30636113 DOI: 10.1103/physrevlett.121.261801] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/17/2018] [Revised: 08/22/2018] [Indexed: 06/09/2023]
Abstract
We present first evidence that the cosine of the CP-violating weak phase 2β is positive, and hence exclude trigonometric multifold solutions of the Cabibbo-Kobayashi-Maskawa (CKM) Unitarity Triangle using a time-dependent Dalitz plot analysis of B^{0}→D^{(*)}h^{0} with D→K_{S}^{0}π^{+}π^{-} decays, where h^{0}∈{π^{0},η,ω} denotes a light unflavored and neutral hadron. The measurement is performed combining the final data sets of the BABAR and Belle experiments collected at the ϒ(4S) resonance at the asymmetric-energy B factories PEP-II at SLAC and KEKB at KEK, respectively. The data samples contain (471±3)×10^{6}BB[over ¯] pairs recorded by the BABAR detector and (772±11)×10^{6}BB[over ¯] pairs recorded by the Belle detector. The results of the measurement are sin2β=0.80±0.14(stat)±0.06(syst)±0.03(model) and cos2β=0.91±0.22(stat)±0.09(syst)±0.07(model). The result for the direct measurement of the angle β of the CKM Unitarity Triangle is β=[22.5±4.4(stat)±1.2(syst)±0.6(model)]°. The measurement assumes no direct CP violation in B^{0}→D^{(*)}h^{0} decays. The quoted model uncertainties are due to the composition of the D^{0}→K_{S}^{0}π^{+}π^{-} decay amplitude model, which is newly established by performing a Dalitz plot amplitude analysis using a high-statistics e^{+}e^{-}→cc[over ¯] data sample. CP violation is observed in B^{0}→D^{(*)}h^{0} decays at the level of 5.1 standard deviations. The significance for cos2β>0 is 3.7 standard deviations. The trigonometric multifold solution π/2-β=(68.1±0.7)° is excluded at the level of 7.3 standard deviations. The measurement resolves an ambiguity in the determination of the apex of the CKM Unitarity Triangle.
Collapse
|
76
|
Gelb M, Bernlochner F, Goldenzweig P, Metzner F, Adachi I, Aihara H, Al Said S, Asner D, Atmacan H, Aushev T, Ayad R, Babu V, Badhrees I, Bansal V, Behera P, Beleño C, Bhuyan B, Biswal J, Bobrov A, Bračko M, Braun N, Cao L, Červenkov D, Chekelian V, Chen A, Cheon B, Chilikin K, Cho K, Choi SK, Choi Y, Choudhury S, Cinabro D, Cunliffe S, Dash N, Di Carlo S, Doležal Z, Dong T, Eidelman S, Epifanov D, Fast J, Ferber T, Frey A, Fulsom B, Garg R, Gaur V, Gabyshev N, Garmash A, Gemmler J, Giri A, Greenwald D, Haba J, Hara T, Hayasaka K, Hayashii H, Hou WS, Inami K, Inguglia G, Ishikawa A, Itoh R, Iwasaki M, Iwasaki Y, Jacobs W, Jia S, Jin Y, Joffe D, Joo K, Kahn J, Kaliyar A, Kawasaki T, Kichimi H, Kiesling C, Kim D, Kim H, Kim S, Kodyš P, Korpar S, Kotchetkov D, Križan P, Kroeger R, Krokovny P, Kuhr T, Kulasiri R, Kuzmin A, Kwon YJ, Lange J, Lee I, Lee J, Lee J, Lee S, Li Y, Li Gioi L, Libby J, Liventsev D, Lu PC, Lubej M, Luo T, MacNaughton J, Masuda M, Merola M, Miyabayashi K, Miyata H, Mizuk R, Mohanty G, Mori T, Mrvar M, Mussa R, Nakao M, Nath K, Natkaniec Z, Nayak M, Niiyama M, Nisar N, Nishida S, Ogawa S, Pakhlov P, Pakhlova G, Pal B, Pardi S, Paul S, Pedlar T, Pestotnik R, Piilonen L, Popov V, Prencipe E, Prim M, Ritter M, Rostomyan A, Russo G, Sahoo D, Sakai Y, Salehi M, Sandilya S, Santelj L, Sanuki T, Savinov V, Schneider O, Schnell G, Schueler J, Schwanda C, Seino Y, Senyo K, Seon O, Sevior M, Shen C, Shibata TA, Shiu JG, Shwartz B, Simon F, Solovieva E, Stanič S, Starič M, Strube J, Sumihama M, Sumiyoshi T, Sutcliffe W, Takizawa M, Tanida K, Tao Y, Tenchini F, Uchida M, Uglov T, Unno Y, Uno S, Urquijo P, Van Tonder R, Varner G, Varvell K, Wang B, Wang C, Wang MZ, Wang P, Wang X, Watanabe M, Watanuki S, Widmann E, Won E, Yamamoto H, Yang S, Ye H, Yin J, Yuan C, Yusa Y, Zakharov S, Zhang Z, Zhilich V, Zhukova V, Zhulanov V. Search for the rare decay of
B+→ℓ+νℓγ
with improved hadronic tagging. Int J Clin Exp Med 2018. [DOI: 10.1103/physrevd.98.112016] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
77
|
Fulsom BG, Pedlar TK, Adachi I, Aihara H, Al Said S, Asner DM, Atmacan H, Aulchenko V, Aushev T, Ayad R, Babu V, Badhrees I, Bakich AM, Bansal V, Behera P, Beleño C, Berger M, Bhardwaj V, Bhuyan B, Bilka T, Biswal J, Bondar A, Bonvicini G, Bozek A, Bračko M, Browder TE, Cao L, Červenkov D, Chekelian V, Chen A, Cheon BG, Chilikin K, Cho K, Choi SK, Choi Y, Choudhury S, Cinabro D, Cunliffe S, Dash N, Di Carlo S, Dingfelder J, Doležal Z, Dong TV, Drásal Z, Eidelman S, Epifanov D, Fast JE, Ferber T, Garg R, Gaur V, Gabyshev N, Garmash A, Gelb M, Giri A, Goldenzweig P, Guido E, Haba J, Hayasaka K, Hayashii H, Hirose S, Hou WS, Iijima T, Inami K, Inguglia G, Ishikawa A, Itoh R, Iwasaki M, Iwasaki Y, Jacobs WW, Jeon HB, Jia S, Jin Y, Joffe D, Joo KK, Julius T, Kawasaki T, Kichimi H, Kiesling C, Kim DY, Kim HJ, Kim JB, Kim KT, Kim SH, Kinoshita K, Kodyš P, Korpar S, Kotchetkov D, Križan P, Kroeger R, Krokovny P, Kuhr T, Kulasiri R, Kuzmin A, Kwon YJ, Lange JS, Lee IS, Lee SC, Li LK, Li YB, Li Gioi L, Libby J, Liventsev D, Lubej M, Luo T, Masuda M, Matsuda T, Matvienko D, Merola M, Miyabayashi K, Miyata H, Mizuk R, Mohanty GB, Moon HK, Mori T, Mussa R, Nakao M, Nanut T, Nath KJ, Natkaniec Z, Nayak M, Niiyama M, Nisar NK, Nishida S, Ogawa S, Okuno S, Ono H, Pakhlov P, Pakhlova G, Pal B, Pardi S, Park H, Paul S, Pestotnik R, Piilonen LE, Popov V, Prencipe E, Rabusov A, Ritter M, Rostomyan A, Russo G, Sakai Y, Salehi M, Sandilya S, Santelj L, Sanuki T, Savinov V, Schneider O, Schnell G, Schwanda C, Seino Y, Senyo K, Sevior ME, Shebalin V, Shen CP, Shibata TA, Shiu JG, Shwartz B, Simon F, Singh JB, Sokolov A, Solovieva E, Starič M, Strube JF, Sumihama M, Sumisawa K, Sumiyoshi T, Sutcliffe W, Takizawa M, Tamponi U, Tanida K, Tenchini F, Uchida M, Uglov T, Unno Y, Uno S, Urquijo P, Vahsen SE, Van Hulse C, Van Tonder R, Varner G, Vinokurova A, Vorobyev V, Vossen A, Wang B, Wang CH, Wang P, Wang XL, Watanabe M, Watanuki S, Widmann E, Won E, Ye H, Yin JH, Yuan CZ, Zhang ZP, Zhilich V, Zhukova V, Zhulanov V, Zupanc A. Observation of ϒ(2S)→γη_{b}(1S) Decay. PHYSICAL REVIEW LETTERS 2018; 121:232001. [PMID: 30576207 DOI: 10.1103/physrevlett.121.232001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/04/2018] [Indexed: 06/09/2023]
Abstract
We report the observation of ϒ(2S)→γη_{b}(1S) decay based on an analysis of the inclusive photon spectrum of 24.7 fb^{-1} of e^{+}e^{-} collisions at the ϒ(2S) center-of-mass energy collected with the Belle detector at the KEKB asymmetric-energy e^{+}e^{-} collider. We measure a branching fraction of B[ϒ(2S)→γη_{b}(1S)]=(6.1_{-0.7-0.6}^{+0.6+0.9})×10^{-4} and derive an η_{b}(1S) mass of 9394.8_{-3.1-2.7}^{+2.7+4.5} MeV/c^{2}, where the uncertainties are statistical and systematic, respectively. The significance of our measurement is greater than 7 standard deviations, constituting the first observation of this decay mode.
Collapse
|
78
|
Watanabe K, Sakamaki K, Ito H, Yokose T, Yamada K, Nakayama H, Masuda M. P3.16-11 Pattern of Recurrence of Completely Resected Lung Adenocarcinoma Varies According to EGFR Mutation Status. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1918] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
79
|
Hara K, Hayashi T, Shimoda Y, Nakazono M, Nagasawa S, Kumazu Y, Yamada T, Rino Y, Masuda M, Ogata T, Oshima T, Yoshikawa T. Can preoperative diagnosis select therapeutic target of neoadjuvant chemotherapy for gastric cancer? Ann Oncol 2018. [DOI: 10.1093/annonc/mdy282.041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
80
|
Hayashi T, Oshima T, Hara K, Shimoda Y, Nakazono M, Nagasawa S, Kumazu Y, Yamada T, Rino Y, Masuda M, Ogata T, Yoshikawa T. The difference of risk factor for gastric cancer surgery between elderly and non-elderly patients. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy282.076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
81
|
Nagasawa S, Ogata T, Hara K, Shimoda Y, Nakazono M, Kumazu Y, Hayashi T, Yamada T, Rino Y, Masuda M, Yoshikawa T, Oshima T. Volume reduction rate of the primary tumor of esophageal squamous cell carcinoma after neoadjuvant chemotherapy: Could this measurement be a surrogate end point for survival before surgery? Ann Oncol 2018. [DOI: 10.1093/annonc/mdy282.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
82
|
Nakazono M, Hayashi T, Akiyama H, Muramatsu M, Tanaka A, Fujii R, Osakabe H, Hara K, Shimoda Y, Nagasawa S, Kumazu Y, Yamada T, Rino Y, Masuda M, Oshima T, Ogata T, Yoshikawa T. Comparison of dietary intake alternation between total and distal gastrectomy. Clin Nutr 2018. [DOI: 10.1016/j.clnu.2018.06.1979] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
83
|
Guido E, Mussa R, Tamponi U, Aihara H, Al Said S, Asner DM, Atmacan H, Aulchenko V, Aushev T, Ayad R, Babu V, Badhrees I, Bakich AM, Bansal V, Behera P, Berger M, Bhardwaj V, Biswal J, Bondar A, Bonvicini G, Bozek A, Bračko M, Browder TE, Červenkov D, Chekelian V, Chen A, Cheon BG, Chilikin K, Cho K, Choi SK, Choi Y, Choudhury S, Cinabro D, Cunliffe S, Di Carlo S, Doležal Z, Eidelman S, Epifanov D, Fast JE, Ferber T, Fulsom BG, Garg R, Gaur V, Gabyshev N, Garmash A, Gelb M, Giri A, Goldenzweig P, Haba J, Hara T, Hayashii H, Hedges MT, Hou WS, Inami K, Inguglia G, Ishikawa A, Itoh R, Iwasaki M, Iwasaki Y, Jacobs WW, Jeon HB, Jia S, Jin Y, Julius T, Kang KH, Karyan G, Kawasaki T, Kiesling C, Kim DY, Kim JB, Kim KT, Kim SH, Kinoshita K, Kodyš P, Korpar S, Kotchetkov D, Križan P, Kroeger R, Krokovny P, Kulasiri R, Kumar R, Kumita T, Kuzmin A, Kwon YJ, Lee IS, Lee SC, Li LK, Li YB, Li Gioi L, Libby J, Liventsev D, Lubej M, Luo T, MacNaughton J, Masuda M, Matsuda T, Matvienko D, Merola M, Miyabayashi K, Miyata H, Mizuk R, Mohanty GB, Moon HK, Mori T, Nakano E, Nakao M, Nanut T, Nath KJ, Nayak M, Niiyama M, Nishida S, Ogawa S, Ono H, Ostrowicz W, Pakhlova G, Pal B, Pardi S, Park CW, Paul S, Pedlar TK, Pestotnik R, Piilonen LE, Popov V, Rostomyan A, Russo G, Sakai Y, Salehi M, Sanuki T, Schneider O, Schnell G, Schwanda C, Seino Y, Shebalin V, Shen CP, Shibata TA, Shiu JG, Shwartz B, Sokolov A, Starič M, Strube JF, Sumihama M, Sumiyoshi T, Takizawa M, Tanida K, Tenchini F, Uchida M, Uglov T, Unno Y, Usov Y, Van Hulse C, Varner G, Vinokurova A, Wang B, Wang CH, Wang MZ, Wang P, Wang XL, Watanabe M, Watanabe Y, Widmann E, Won E, Ye H, Yelton J, Yuan CZ, Yusa Y, Zakharov S, Zhang ZP, Zhilich V, Zhukova V, Zhulanov V. Observation of ϒ(4S)→η^{'}ϒ(1S). PHYSICAL REVIEW LETTERS 2018; 121:062001. [PMID: 30141661 DOI: 10.1103/physrevlett.121.062001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/27/2018] [Revised: 07/11/2018] [Indexed: 06/08/2023]
Abstract
We report the first observation of the hadronic transition ϒ(4S)→η^{'}ϒ(1S), using 496 fb^{-1} data collected at the ϒ(4S) resonance with the Belle detector at the KEKB asymmetric-energy e^{+}e^{-} collider. We reconstruct the η^{'} meson through its decays to ρ^{0}γ and to π^{+}π^{-}η, with η→γγ. We measure B(ϒ(4S)→η^{'}ϒ(1S))=[3.43±0.88(stat)±0.21(syst)]×10^{-5}, with a significance of 5.7σ.
Collapse
|
84
|
Yelton J, Adachi I, Ahn JK, Aihara H, Al Said S, Asner DM, Atmacan H, Aushev T, Ayad R, Babu V, Badhrees I, Bahinipati S, Bakich AM, Bansal V, Beleño C, Berger M, Bhardwaj V, Bhuyan B, Bilka T, Biswal J, Bondar A, Bonvicini G, Bozek A, Bračko M, Browder TE, Červenkov D, Chekelian V, Chen A, Cheon BG, Chilikin K, Cho K, Choi SK, Choi Y, Choudhury S, Cinabro D, Cunliffe S, Czank T, Dash N, Di Carlo S, Doležal Z, Dong TV, Drásal Z, Eidelman S, Epifanov D, Fast JE, Fulsom BG, Garg R, Gaur V, Gabyshev N, Garmash A, Gelb M, Giri A, Goldenzweig P, Greenwald D, Guido E, Haba J, Hayasaka K, Hayashii H, Hirose S, Hou WS, Inami K, Inguglia G, Ishikawa A, Itoh R, Iwasaki M, Iwasaki Y, Jacobs WW, Jeon HB, Jia S, Jin Y, Joo KK, Julius T, Kaliyar AB, Kang KH, Karyan G, Kato Y, Kiesling C, Kim DY, Kim JB, Kim KT, Kim SH, Kinoshita K, Kodyš P, Korpar S, Kotchetkov D, Križan P, Kroeger R, Krokovny P, Kuhr T, Kumar R, Kuzmin A, Kwon YJ, Lange JS, Lee IS, Lee SC, Li LK, Li YB, Li Gioi L, Libby J, Liventsev D, Lubej M, Luo T, Masuda M, Matsuda T, Matvienko D, McNeil JT, Merola M, Miyabayashi K, Miyata H, Mizuk R, Mohanty GB, Moon HK, Mori T, Mussa R, Nakano E, Nakao M, Nanut T, Nath KJ, Natkaniec Z, Niiyama M, Nisar NK, Nishida S, Ono H, Pakhlov P, Pakhlova G, Pal B, Pardi S, Park H, Paul S, Pedlar TK, Pestotnik R, Piilonen LE, Popov V, Ritter M, Russo G, Sahoo D, Sakai Y, Sandilya S, Santelj L, Sanuki T, Savinov V, Schneider O, Schnell G, Schwanda C, Seino Y, Senyo K, Sevior ME, Shebalin V, Shen CP, Shibata TA, Shiu JG, Shwartz B, Simon F, Sokolov A, Solovieva E, Starič M, Strube JF, Sumihama M, Sumiyoshi T, Suzuki K, Takizawa M, Tamponi U, Tanida K, Tao Y, Tenchini F, Uchida M, Uglov T, Uno S, Urquijo P, Usov Y, Vahsen SE, Van Hulse C, Varner G, Vorobyev V, Vossen A, Wang B, Wang CH, Wang MZ, Wang P, Wang XL, Watanabe M, Watanuki S, Widmann E, Won E, Ye H, Yuan CZ, Yusa Y, Zakharov S, Zhang ZP, Zhilich V, Zhukova V, Zhulanov V. Observation of an Excited Ω^{-} Baryon. PHYSICAL REVIEW LETTERS 2018; 121:052003. [PMID: 30118260 DOI: 10.1103/physrevlett.121.052003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/23/2018] [Indexed: 06/08/2023]
Abstract
Using data recorded with the Belle detector, we observe a new excited hyperon, an Ω^{*-} candidate decaying into Ξ^{0}K^{-} and Ξ^{-}K_{S}^{0} with a mass of 2012.4±0.7(stat)±0.6(syst) MeV/c^{2} and a width of Γ=6.4_{-2.0}^{+2.5}(stat)±1.6(syst) MeV. The Ω^{*-} is seen primarily in ϒ(1S),ϒ(2S), and ϒ(3S) decays.
Collapse
|
85
|
Hata Y, Iida O, Asai M, Masuda M, Okamoto S, Ishihara T, Nanto K, Kanda T, Tsujimura T, Okuno S, Matsuda Y, Takahara M, Mano T. P1633Further risk stratification by systemic factors in WIfI (Wound, Ischemia, and foot Infection classification system) stage 4 but not in stage 1-3 in critical limb ischemia. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.p1633] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
86
|
Kanda T, Masuda M, Shizuta S, Kobori S, Inoue K, Kaitani K, Kurotobi T, Morishima I, Nakazawa Y, Matsuda Y, Iida O, Asai M, Mano T. P997Factors associated with quality-of-life improvement after catheter ablation of asymptomatic persistent atrial fibrillation: insights from the Kansai Plus Atrial Fibrillation (KPAF) Registry. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy564.p997] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
87
|
Yonishi T, Minamiguchi J, Shiraki T, Matsuda Y, Ozu K, Kanda T, Masuda M, Miyoshi M, Mizote I, Mizuno Y, Hikoso S, Sakata Y. P6599Clinical impact of thyroxin levels on recurrence of atrial fibrillation after catheter ablation for patients without thyroid dysfunction: a multicenter study. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p6599] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
88
|
Sibidanov A, Varvell KE, Adachi I, Aihara H, Al Said S, Asner DM, Aushev T, Ayad R, Babu V, Badhrees I, Bahinipati S, Bakich AM, Bansal V, Barberio E, Behera P, Bhuyan B, Biswal J, Bozek A, Bračko M, Browder TE, Červenkov D, Chang P, Chekelian V, Chen A, Cheon BG, Chilikin K, Cho K, Choi SK, Choi Y, Cinabro D, Czank T, Dash N, Di Carlo S, Doležal Z, Drásal Z, Dutta D, Eidelman S, Epifanov D, Fast JE, Ferber T, Fulsom BG, Gaur V, Gabyshev N, Garmash A, Goldenzweig P, Greenwald D, Guan Y, Guido E, Haba J, Hayasaka K, Hayashii H, Hedges MT, Hirose S, Hou WS, Hsu CL, Iijima T, Inami K, Inguglia G, Ishikawa A, Itoh R, Iwasaki M, Iwasaki Y, Jacobs WW, Jaegle I, Jeon HB, Jin Y, Joo KK, Julius T, Kahn J, Kaliyar AB, Kang KH, Karyan G, Kawasaki T, Kiesling C, Kim DY, Kim JB, Kim SH, Kim YJ, Kinoshita K, Kodyš P, Korpar S, Kotchetkov D, Križan P, Krokovny P, Kuhr T, Kulasiri R, Kumar R, Kuzmin A, Kwon YJ, Lange JS, Lee IS, Li CH, Li L, Li Gioi L, Libby J, Liventsev D, Lubej M, Luo T, Masuda M, Matsuda T, Merola M, Miyabayashi K, Miyata H, Mizuk R, Mohanty GB, Moon HK, Mori T, Mussa R, Nakano E, Nakao M, Nanut T, Nath KJ, Natkaniec Z, Nayak M, Niiyama M, Nisar NK, Nishida S, Ogawa S, Okuno S, Ono H, Pakhlov P, Pakhlova G, Pal B, Park CS, Park CW, Park H, Paul S, Pedlar TK, Pestotnik R, Piilonen LE, Ritter M, Rostomyan A, Rozanska M, Sakai Y, Salehi M, Sandilya S, Sato Y, Savinov V, Schneider O, Schnell G, Schwanda C, Seino Y, Senyo K, Sevior ME, Shebalin V, Shen CP, Shibata TA, Shiu JG, Simon F, Sokolov A, Solovieva E, Starič M, Strube JF, Stypula J, Sumihama M, Sumisawa K, Sumiyoshi T, Takizawa M, Tamponi U, Tanida K, Tenchini F, Trabelsi K, Uchida M, Uehara S, Uglov T, Unno Y, Uno S, Urquijo P, Van Hulse C, Varner G, Vorobyev V, Wang CH, Wang MZ, Wang P, Watanabe M, Watanuki S, Widmann E, Won E, Yamashita Y, Ye H, Yelton J, Yuan CZ, Yusa Y, Zhang ZP, Zhilich V, Zhukova V, Zhulanov V, Zupanc A. Search for B^{-}→μ^{-}ν[over ¯]_{μ} Decays at the Belle Experiment. PHYSICAL REVIEW LETTERS 2018; 121:031801. [PMID: 30085771 DOI: 10.1103/physrevlett.121.031801] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/12/2017] [Revised: 05/01/2018] [Indexed: 06/08/2023]
Abstract
We report the results of a search for the rare, purely leptonic decay B^{-}→μ^{-}ν[over ¯]_{μ} performed with a 711 fb^{-1} data sample that contains 772×10^{6} BB[over ¯] pairs, collected near the ϒ(4S) resonance with the Belle detector at the KEKB asymmetric-energy e^{+}e^{-} collider. The signal events are selected based on the presence of a high momentum muon and the topology of the rest of the event showing properties of a generic B-meson decay, as well as the missing energy and momentum being consistent with the hypothesis of a neutrino from the signal decay. We find a 2.4 standard deviation excess above background including systematic uncertainties, which corresponds to a branching fraction of B(B^{-}→μ^{-}ν[over ¯]_{μ})=(6.46±2.22±1.60)×10^{-7} or a frequentist 90% confidence level interval on the B^{-}→μ^{-}ν[over ¯]_{μ} branching fraction of [2.9,10.7]×10^{-7}.
Collapse
|
89
|
Sugano T, Masuda M, Uno Y, Goto N, Seike M, Sawa M, Gemma A, Yamada T. Abstract 2034: Traf2-and Nck-interacting kinase (TNIK) inhibitor, NCB-0846, suppresses TGF-β1-induced epithelial-mesenchymal transition in lung cancer. Cancer Res 2018. [DOI: 10.1158/1538-7445.am2018-2034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Epithelial mesenchymal transition (EMT) has been implicated in cancer cell migration, invasion, and metastasis. Transforming growth factor-β (TGF-β) signal was known to be an essential EMT promotor. Development of therapeutics for targeting EMT through the TGF-β signal may be beneficial for the management of cancer metastasis. Recently, we found that a Traf2- and Nck-interacting kinase (TNIK) inhibitor, named NCB-0846, was capable of attenuating tumor-initiating cells among human colorectal cancer (1, 2). The cross link between EMT and cancer stemness has been revealed in several studies. Therefore we evaluated whether this small-molecule compound could have efficacy to inhibit TGF-β-induced EMT. NCB-0846 reduced the expression of mesenchymal markers (Vimentin and N-cadherin) and upregulated the expression of epithelial marker E-cadherin in A549 and H2228 cells. NCB-0846 suppressed the phosphorylation and nuclear translocation of Smad proteins and also inhibited migration, invasion, and metastasis. NCB-0846 inhibited TGF-β1-induced EMT through the down-regulation of TGFBR1 in mRNA levels. MiR-186-5p and miR-320 family were identified as candidate miRNAs that could target TGFBR1 and inhibited TGFBR1 protein expression.NCB-0846 might be a novel therapeutics drugs that targets the invasion and metastasis through inhibiting TGF-β-induced EMT in lung cancer.
1. Masuda M, Sawa M, Yamada T. Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer. Pharmacology & therapeutics. 2015;156:1-9. Epub 2015/11/07.2. Masuda M, Uno Y, Ohbayashi N, Ohata H, Mimata A, Kukimoto-Niino M, et al. TNIK inhibition abrogates colorectal cancer stemness. Nature communications. 2016;7:12586. Epub 2016/08/27.
Citation Format: Teppei Sugano, Mari Masuda, Yuko Uno, Naoko Goto, Masahiro Seike, Masaaki Sawa, Akihiko Gemma, Tesshi Yamada. Traf2-and Nck-interacting kinase (TNIK) inhibitor, NCB-0846, suppresses TGF-β1-induced epithelial-mesenchymal transition in lung cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 2034.
Collapse
|
90
|
Iwaya T, Endo F, Sasaki Y, Akiyama Y, Sasaki A, Masuda M, Yamada T, Tokino T, Nishizuka S. Therapeutic response monitoring using digital PCR for patient-specific circulating tumor DNA identified by an esophageal squamous cell carcinoma-specific sequencing panel. J Clin Oncol 2018. [DOI: 10.1200/jco.2018.36.15_suppl.e24089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
91
|
Grygier J, Goldenzweig P, Heck M, Adachi I, Aihara H, Al Said S, Asner D, Aushev T, Ayad R, Aziz T, Babu V, Badhrees I, Bahinipati S, Bakich A, Bansal V, Barberio E, Behera P, Bhuyan B, Biswal J, Bobrov A, Bondar A, Bonvicini G, Bozek A, Bračko M, Browder T, Červenkov D, Chang P, Chekelian V, Chen A, Cheon B, Chilikin K, Chistov R, Cho K, Choi Y, Cinabro D, Dash N, Di Carlo S, Doležal Z, Drásal Z, Dutta D, Eidelman S, Farhat H, Fast J, Ferber T, Fulsom B, Gaur V, Gabyshev N, Garmash A, Gelb M, Gillard R, Golob B, Grzymkowska O, Guido E, Haba J, Hara T, Hayasaka K, Hayashii H, Hedges M, Hsu CL, Iijima T, Inami K, Inguglia G, Ishikawa A, Itoh R, Iwasaki Y, Jacobs W, Jaegle I, Jeon H, Jin Y, Joffe D, Joo K, Julius T, Kahn J, Kaliyar A, Kang K, Karyan G, Katrenko P, Kawasaki T, Keck T, Kichimi H, Kiesling C, Kim D, Kim H, Kim J, Kim K, Kim M, Kim S, Kinoshita K, Kodyš P, Korpar S, Kotchetkov D, Križan P, Krokovny P, Kuhr T, Kulasiri R, Kumita T, Kuzmin A, Kwon YJ, Lange J, Li C, Li L, Li Y, Li Gioi L, Libby J, Liventsev D, Lubej M, Luo T, Masuda M, Matsuda T, Matvienko D, Metzner F, Miyabayashi K, Miyake H, Miyata H, Mizuk R, Mohanty G, Moon H, Mori T, Mussa R, Nakano E, Nakao M, Nanut T, Nath K, Natkaniec Z, Nayak M, Nisar N, Nishida S, Ogawa S, Okuno S, Ono H, Onuki Y, Pakhlova G, Pal B, Park CS, Park C, Park H, Paul S, Pedlar T, Pesántez L, Piilonen L, Prim M, Pulvermacher C, Ritter M, Rostomyan A, Sakai Y, Sandilya S, Santelj L, Sanuki T, Sato Y, Savinov V, Schlüter T, Schneider O, Schnell G, Schwanda C, Schwartz A, Seino Y, Senyo K, Seong I, Sevior M, Shebalin V, Shen C, Shibata TA, Shiu JG, Shwartz B, Simon F, Solovieva E, Starič M, Strube J, Sumiyoshi T, Takizawa M, Tamponi U, Tenchini F, Trabelsi K, Tsuboyama T, Uchida M, Uglov T, Unno Y, Uno S, Urquijo P, Ushiroda Y, Van Hulse C, Varner G, Vorobyev V, Vossen A, Waheed E, Wang B, Wang C, Wang MZ, Wang P, Watanabe M, Watanabe Y, Wehle S, Williams K, Won E, Yamamoto H, Yamashita Y, Ye H, Yook Y, Yuan C, Yusa Y, Zhang Z, Zhilich V, Zhukova V, Zhulanov V, Ziegler M, Zupanc A. Publisher’s Note: Search for
B→hνν¯
decays with semileptonic tagging at Belle [Phys. Rev. D
96
, 091101(R) (2017)]. Int J Clin Exp Med 2018. [DOI: 10.1103/physrevd.97.099902 10.1103/physrevd.96.091101] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
92
|
Exposto FG, Masuda M, Castrillon EE, Svensson P. Effects of nerve growth factor experimentally-induced craniofacial muscle sensitization on referred pain frequency and number of headache days: A double-blind, randomized placebo-controlled study. Cephalalgia 2018. [PMID: 29528692 DOI: 10.1177/0333102418758481] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
OBJECTIVE To assess if repeated intramuscular injections of nerve growth factor into the temporalis and masseter muscles increase mechanical sensitivity and entropy scores. Furthermore, to investigate if increased mechanical sensitivity would lead to increased prevalence of referred pain in the studied individuals. Finally, if increased muscle sensitization would lead to an increase in number of headache days during the experimental period. METHODS The present double-blind, randomized placebo-controlled study recruited 16 healthy participants who were injected with nerve growth-factor, on 2 days, into the masseter and temporalis muscles and isotonic saline on the contralateral side. Mechanical sensitivity was assessed at seven different time-points (total of 21 days) by application of three different forces to 15 different sites of both muscles. Participants were asked after each force application if they experienced referred pain and were asked to keep a headache diary during the experimental period. RESULTS In summary, a) repeated intramuscular injections of nerve-growth-factor caused an increase in mechanical sensitivity for the masseter but not the temporalis muscle, and an increase in entropy scores when compared to the isotonic saline side. b) Both referred pain frequency and number of headache days were not increased following nerve-growth-factor injections. CONCLUSIONS These findings support the idea that mechanical sensitization in the masseter and temporalis muscles differs following injections of nerve growth factor. Furthermore, referred pain and headache frequency do not seem to be related to nerve growth factor sensitization in this model. These findings support the idea that in healthy individuals referred pain may be an epiphenomenon of the muscle in response to noxious input.
Collapse
|
93
|
Masuda M, Kanda T, Matsuda Y, Ohashi T, Tsuji A, Mano T. P356Pace-capture-guided ablation after contact-force-guided pulmonary vein isolation: Results of the randomized controlled DRAGON trial. Europace 2018. [DOI: 10.1093/europace/euy015.167] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
94
|
Masuda M, Kanda T, Matsuda Y, Ohashi T, Tsuji A, Mano T. P773Centrifugal wave-front propagation speed for localizing the origin of ventricular arrhythmias: Investigation using a new ultra-high-resolution mapping system. Europace 2018. [DOI: 10.1093/europace/euy015.377] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
95
|
Matsuda Y, Masuda M, Asai M, Iida O, Okamoto S, Ishihara T, Nanto K, Kanda T, Tsujimura T, Okuno S, Ohashi T, Kawai H, Tsuji A, Hata Y, Mano T. P1201The association with p-wave duration and the prevalence of left atrial low-voltage areas. Europace 2018. [DOI: 10.1093/europace/euy015.683] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
96
|
Matsuda Y, Masuda M, Asai M, Iida O, Okamoto S, Ishihara T, Nanto K, Kanda T, Tsujimura T, Okuno S, Ohashi T, Kawai H, Tsuji A, Hata Y, Mano T. P1169Severity of chronic kidney disease predicts the prevalence of left atrial low-voltage areas. Europace 2018. [DOI: 10.1093/europace/euy015.654] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
97
|
Takahashi M, Masuda M, Isiglo K, Matsumoto T. Computer-Linked Memorandum of Pathology System (CLIMPS 7909) for Interactive Storage and Analysis of Surgical Pathology Data. Methods Inf Med 2018. [DOI: 10.1055/s-0038-1635273] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
A new interactive data base management system for surgical pathology is described which was developed by modification of the previously reported system for autopsy records [23]. As the name implies, it serves as a personal memorandum. Always led by the computer, it is easy to write and read, whenever necessary, without knowledge of programming or data format. The outstanding features are its flexibility of operation and the on-line availability of simple statistical data on some items (diagnoses, topography, histology, age and sex) in response to the specification of search condition so that it provides an opportunity to expand association of ideas during the process of diagnosis and serves as a diagnostic support system. The CLIMPS has been successfully tested with over 770 surgical pathology records. Some problems to be expected in the future are discussed.
Collapse
|
98
|
Uno Y, Moriyama H, Kashimoto S, Masuda M, Sawa M, Yamada T. Abstract B146: A novel TNIK inhibitor potently downregulates cancer stem cell population through attenuation of Wnt signaling. Mol Cancer Ther 2018. [DOI: 10.1158/1535-7163.targ-17-b146] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: TNIK (Traf2- and Nck-interacting kinase) has been identified as a component of the β-catenin and T-cell factor 4 (TCF4) complex that regulates the downstream of Wnt signaling. Recent studies indicated that the Wnt pathway is highly activated in cancer stem cells (CSCs), which have been recognized as the driving force of tumorigenesis and mediating tumor recurrence. Thus, eradicating CSCs by inhibiting Wnt signaling may become a new therapeutic option for a complete cure of cancers. Recently we have demonstrated that TNIK is required for the tumor-initiating function of colorectal CSCs, and therefore TNIK is considered to be attractive targets for drug discovery. We have discovered a thiazole-based TNIK inhibitor having potent inhibitory activity for the Wnt signaling. Further optimization of the thiazole-based TNIK inhibitor resulted in an orally available novel TNIK inhibitor, NC-1. In this study, we evaluated in vivo efficacy of the TNIK inhibitor in mouse models as well as its effects on CSCs in vitro. Materials and Methods: To evaluate the effects of NC-1 on the CSCs in SW620, human colon cancer cells, the enzymatic activity of aldehyde dehydrogenase (ALDH) was analyzed by flow cytometry using an Aldefluor assay. The expression of CSCs surface marker protein, CD133, was analyzed using flow cytometry. Antitumor efficacy of NC-1 was evaluated in a human colorectal tumor xenograft mouse model. Results: We demonstrated that treatment of cancer cells with NC-1 significantly downregulated ALDH positive cell population in a dose-dependent manner. In addition, NC-1 suppressed cell surface expression of CD133 in a dose-dependent manner, suggesting that NC-1 preferentially killed CSCs population in vitro. Furthermore, NC-1 inhibited tumor growth in the HCT116 xenograft mouse model.
Citation Format: Yuko Uno, Hideki Moriyama, Shigeki Kashimoto, Mari Masuda, Masaaki Sawa, Tesshi Yamada. A novel TNIK inhibitor potently downregulates cancer stem cell population through attenuation of Wnt signaling [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2017 Oct 26-30; Philadelphia, PA. Philadelphia (PA): AACR; Mol Cancer Ther 2018;17(1 Suppl):Abstract nr B146.
Collapse
|
99
|
Horiguchi T, Ishikawa A, Yamamoto H, Adachi I, Aihara H, Al Said S, Asner DM, Aulchenko V, Aushev T, Ayad R, Babu V, Badhrees I, Bakich AM, Bansal V, Behera P, Bhardwaj V, Bhuyan B, Biswal J, Bobrov A, Bonvicini G, Bozek A, Bračko M, Browder TE, Červenkov D, Chekelian V, Chen A, Cheon BG, Chilikin K, Cho K, Choi Y, Cinabro D, Czank T, Dash N, Di Carlo S, Doležal Z, Drásal Z, Dutta D, Eidelman S, Epifanov D, Farhat H, Fast JE, Ferber T, Fulsom BG, Gaur V, Gabyshev N, Garmash A, Gelb M, Gillard R, Goldenzweig P, Golob B, Guan Y, Guido E, Haba J, Hara T, Hayasaka K, Hayashii H, Hedges MT, Higuchi T, Hirose S, Hou WS, Iijima T, Inami K, Inguglia G, Itoh R, Iwasaki Y, Jacobs WW, Jaegle I, Jeon HB, Jia S, Jin Y, Joffe D, Joo KK, Julius T, Kang KH, Kawasaki T, Kim DY, Kim JB, Kim KT, Kim MJ, Kim SH, Kim YJ, Kinoshita K, Kodyš P, Korpar S, Kotchetkov D, Križan P, Krokovny P, Kuhr T, Kulasiri R, Kumar R, Kumita T, Kuzmin A, Kwon YJ, Lange JS, Li CH, Li L, Li Gioi L, Libby J, Liventsev D, Lubej M, Luo T, Masuda M, Matsuda T, Matvienko D, Merola M, Miyabayashi K, Miyata H, Mizuk R, Mohanty GB, Mohanty S, Moon HK, Mori T, Mussa R, Nakano E, Nakao M, Nanut T, Nath KJ, Natkaniec Z, Nayak M, Nisar NK, Nishida S, Ogawa S, Okuno S, Ono H, Pakhlov P, Pakhlova G, Pal B, Pardi S, Park CS, Park H, Paul S, Pedlar TK, Pestotnik R, Piilonen LE, Prasanth K, Pulvermacher C, Rauch J, Rostomyan A, Sakai Y, Sandilya S, Santelj L, Savinov V, Schneider O, Schnell G, Schwanda C, Schwartz AJ, Seino Y, Senyo K, Seong IS, Sevior ME, Shebalin V, Shen CP, Shibata TA, Shiu JG, Simon F, Sokolov A, Solovieva E, Starič M, Strube JF, Sumisawa K, Sumiyoshi T, Takizawa M, Tamponi U, Tanida K, Tenchini F, Trabelsi K, Uchida M, Uglov T, Unno Y, Uno S, Urquijo P, Ushiroda Y, Usov Y, Van Hulse C, Varner G, Vinokurova A, Vorobyev V, Vossen A, Wang CH, Wang MZ, Wang P, Watanabe Y, Watanuki S, Weber T, Widmann E, Won E, Yamashita Y, Ye H, Zhang ZP, Zhilich V, Zhukova V, Zhulanov V, Zupanc A. Evidence for Isospin Violation and Measurement of CP Asymmetries in B→K^{*}(892)γ. PHYSICAL REVIEW LETTERS 2017; 119:191802. [PMID: 29219495 DOI: 10.1103/physrevlett.119.191802] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/29/2017] [Indexed: 06/07/2023]
Abstract
We report the first evidence for isospin violation in B→K^{*}γ and the first measurement of the difference of CP asymmetries between B^{+}→K^{*+}γ and B^{0}→K^{*0}γ. This analysis is based on the data sample containing 772×10^{6}BB[over ¯] pairs that was collected with the Belle detector at the KEKB energy-asymmetric e^{+}e^{-} collider. We find evidence for the isospin violation with a significance of 3.1σ, Δ_{0+}=[+6.2±1.5(stat)±0.6(syst)±1.2(f_{+-}/f_{00})]%, where the third uncertainty is due to the uncertainty on the fraction of B^{+}B^{-} to B^{0}B[over ¯]^{0} production in ϒ(4S) decays. The measured value is consistent with predictions of the standard model. The result for the difference of CP asymmetries is ΔA_{CP}=[+2.4±2.8(stat)±0.5(syst)]%, consistent with zero. The measured branching fractions and CP asymmetries for charged and neutral B meson decays are the most precise to date. We also calculate the ratio of branching fractions of B^{0}→K^{*0}γ to B_{s}^{0}→ϕγ.
Collapse
|
100
|
Nakazono M, Hayashi T, Yamada T, Osakabe H, Hara K, Nagasawa S, Kumazu Y, Rino Y, Masuda M, Ogata T, Yoshikawa T. Priority of lymphadenectomy for each station in elderly patients with middle to distal advanced gastric cancer. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx660.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|